Urology & Nephrology Podcasts Urology & Nephrology RSS feedThis is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

Prostate and Kidney Cancer Studies Awaiting Determinnation from FDA
Sarmad Sadeghi, MD, PhD, discusses studies that are awaiting determinations fom the FDA. Author: Annual-Meeting Added: 08/21/2019 (Source: Oncology Tube)
Source: Oncology Tube - August 22, 2019 Category: Cancer & Oncology Source Type: podcasts

FDA Drug Safety Podcast: FDA adds Boxed Warning to highlight correct dosing of Ocaliva (obeticholic acid) for patients with a rare chronic liver disease
Listen to an audio podcast of the February 1, 2018 FDA Drug Safety Communication warning that the liver disease medicine Ocaliva (obeticholic acid) has been incorrectly dosed daily instead of weekly in patients with moderate to severe primary biliary cholangitis, increasing the risk of serious liver injury. (Source: FDA Drug Safety Podcasts)
Source: FDA Drug Safety Podcasts - July 12, 2019 Category: Drugs & Pharmacology Authors: FDA Source Type: podcasts

JAMA Internal Medicine : Association of Weight Loss Interventions With Changes in NAFLD Biomarkers
Interview with Dimitrios A. Koutoukidis, PhD, author of Association of Weight Loss Interventions With Changes in Biomarkers of Nonalcoholic Fatty Liver Disease: A Systematic Review and Meta-analysis (Source: JAMA Specialty Journals Author Interviews)
Source: JAMA Specialty Journals Author Interviews - July 1, 2019 Category: General Medicine Source Type: podcasts

COSMIC-312 Trial in HCC
Daneng Li, MD, Assistant Clinical Professor, Department of Medical Oncology & Therapeutics Research, Liver Program Disease Team Lead, City of Hope explains the design of the COSMIC-312 study in hepato... Author: obr Added: 06/28/2019 (Source: Oncology Tube)
Source: Oncology Tube - June 28, 2019 Category: Cancer & Oncology Source Type: podcasts

The Next Steps if an HCC Patient Fails 1st Line Therapy
Daneng Li, MD, Assistant Clinical Professor, Department of Medical Oncology & Therapeutics Research, Liver Program Disease Team Lead, City of Hope offers the next steps if a hepatocellular carcinoma (... Author: obr Added: 06/28/2019 (Source: Oncology Tube)
Source: Oncology Tube - June 28, 2019 Category: Cancer & Oncology Source Type: podcasts

The Role of I-O in Managing HCC
Daneng Li, MD, Assistant Clinical Professor, Department of Medical Oncology & Therapeutics Research, Liver Program Disease Team Lead, City of Hope, gives his take on the role of immuno-oncology (I-O) ... Author: obr Added: 06/28/2019 (Source: Oncology Tube)
Source: Oncology Tube - June 28, 2019 Category: Cancer & Oncology Source Type: podcasts

KEYNOTE 240 Outcomes
Daneng Li, MD, Assistant Clinical Professor, Department of Medical Oncology & Therapeutics Research, Liver Program Disease Team Lead, City of Hope, explains the outcomes from KEYNOTe 240 trial compari... Author: obr Added: 06/28/2019 (Source: Oncology Tube)
Source: Oncology Tube - June 28, 2019 Category: Cancer & Oncology Source Type: podcasts

FDA Drug Safety Podcast: FDA adds Boxed Warning to highlight correct dosing of Ocaliva (obeticholic acid) for patients with a rare chronic liver disease
Listen to an audio podcast of the February 1, 2018 FDA Drug Safety Communication warning that the liver disease medicine Ocaliva (obeticholic acid) has been incorrectly dosed daily instead of weekly in patients with moderate to severe primary biliary cholangitis, increasing the risk of serious liver injury. (Source: FDA Drug Safety Podcasts)
Source: FDA Drug Safety Podcasts - June 20, 2019 Category: Drugs & Pharmacology Authors: FDA Source Type: podcasts

Immunosuppressive treatment for people with proliferative lupus nephritis
Systemic lupus erythematosus, or SLE, is an autoimmune disease that can affect any part of the body. About half the people with it develop lupus nephritis. In the June 2018 update of their Cochrane Review, David Tunnicliffe from the Centre for Kidney Research in the Children ’s Hospital at Westmead and the University of Sydney’s School of Public Health in Australia and colleagues brought together the studies that have tested a range of treatments. (Source: Podcasts from The Cochrane Library)
Source: Podcasts from The Cochrane Library - May 28, 2019 Category: General Medicine Authors: Cochrane Source Type: podcasts

Richard S. Finn, MD / Laura M. Kulik, MD - Rethinking Care in Hepatocellular Carcinoma Amid Expanding Treatment Options: An Interdisciplinary Discussion
Go online to PeerView.com/PDD860 to view the activity, download slides and practice aids, and complete the post-test to earn credit. In this activity, a multidisciplinary panel of interventional radiology, hepatology, and medical oncology experts provide an in-depth analysis of the latest data for approved and emerging systemic treatment options and recent evidence on locoregional and multimodal approaches for patients with HCC. In addition, the expert panel provides guidance on strategies to optimally select and timely transition between locoregional and systemic therapies. Upon completion of this activity, participants s...
Source: PeerView CME/CE Audio Podcast - Immunology - May 24, 2019 Category: Allergy & Immunology Authors: PVI, PeerView Institute for Medical Education Tags: Science, Medicine Source Type: podcasts

Novel Oral HIF-2 Alpha Inhibitor PT2977
Toni Choueiri M.D. Director of the Lank Center for Genitourinary (GU) Oncology at Dana-Farber Cancer Institute/Brigham and Womens Hospital and the Jerome and Nancy Kohlberg Chair and Professor of Med... Author: kidneycancer Added: 04/17/2019 (Source: Oncology Tube)
Source: Oncology Tube - April 17, 2019 Category: Cancer & Oncology Source Type: podcasts

mTOR & PI3 Kinase Inhibitor Study
Toni Choueiri M.D. Director of the Lank Center for Genitourinary (GU) Oncology at Dana-Farber Cancer Institute/Brigham and Womens Hospital and the Jerome and Nancy Kohlberg Chair and Professor of Med... Author: kidneycancer Added: 04/17/2019 (Source: Oncology Tube)
Source: Oncology Tube - April 17, 2019 Category: Cancer & Oncology Source Type: podcasts

Elaborating On Frontline Therapies
Toni Choueiri M.D. Director of the Lank Center for Genitourinary (GU) Oncology at Dana-Farber Cancer Institute/Brigham and Womens Hospital and the Jerome and Nancy Kohlberg Chair and Professor of Med... Author: kidneycancer Added: 04/17/2019 (Source: Oncology Tube)
Source: Oncology Tube - April 17, 2019 Category: Cancer & Oncology Source Type: podcasts

No OS Signal in Axitinib + Avelumab Combination Therapy
Toni Choueiri M.D. Director of the Lank Center for Genitourinary (GU) Oncology at Dana-Farber Cancer Institute/Brigham and Womens Hospital and the Jerome and Nancy Kohlberg Chair and Professor of Med... Author: kidneycancer Added: 04/17/2019 (Source: Oncology Tube)
Source: Oncology Tube - April 17, 2019 Category: Cancer & Oncology Source Type: podcasts

Remembering Martin Gore
David Quinn M.D., PhD Associate Professor of Medicine (Clinical Scholar);Section Head, Genitourinary (GU) Oncology, Division of Cancer Medicine and Blood Diseases in the Department of Medicine At The ... Author: kidneycancer Added: 04/17/2019 (Source: Oncology Tube)
Source: Oncology Tube - April 17, 2019 Category: Cancer & Oncology Source Type: podcasts